Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-11 Purchase |
2022-05-13 5:48 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
192,516 | $2.1841 | $420,482 | 18,389,422 (Indirect) |
View |
| 2022-05-06 Purchase |
2022-05-10 6:19 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
125,359 | $1.5735 | $197,252 | 18,196,906 (Indirect) |
View |
| 2022-02-11 Purchase |
2022-02-15 9:51 pm |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director |
195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) |
View |
| 2022-01-19 Purchase |
2022-01-21 7:22 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
158,417 | $9.9656 | $1,578,717 | 17,041,802 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 7:27 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
44,717 | $9.9012 | $442,750 | 16,883,385 (Indirect) |
View |
| 2021-11-04 Purchase |
2021-11-08 9:12 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
5,357,143 | $3.5 | $18,750,001 | 3,571,428 (Indirect) |
View |
| 2021-10-12 Purchase |
2021-10-14 5:00 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
625,000 | $16 | $10,000,000 | 499,150 (Indirect) |
View |
| 2021-03-29 Sale |
2021-03-31 5:11 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
103,424 | $23.48 | $2,428,092 | 2,212,571 (Indirect) |
View |
| 2021-03-24 Sale |
2021-03-26 5:46 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
112,298 | $24.53 | $2,754,247 | 2,315,995 (Indirect) |
View |
| 2021-03-19 Sale |
2021-03-23 5:26 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
32,940 | $26.21 | $863,339 | 2,428,293 (Indirect) |
View |
| 2021-03-16 Sale |
2021-03-18 9:04 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
66,202 | $27.95 | $1,850,339 | 2,461,233 (Indirect) |
View |
| 2021-03-11 Sale |
2021-03-15 8:50 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
238,282 | $30.54 | $7,275,986 | 2,527,435 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:10 pm |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
475,000 | $17 | $8,075,000 | 2,274,723 (Indirect) |
View |
| 2020-12-02 Purchase |
2020-12-04 5:13 pm |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
750,000 | $20 | $15,000,000 | 450,000 (Indirect) |
View |
| 2020-06-19 Purchase |
2020-06-23 9:37 pm |
Compass Therapeutics Inc. | GORDON CARL L Director 10% Owner |
1,455,132 | $5 | $7,275,660 | 12,714,404 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-16 Option Award |
2022-06-21 9:00 pm |
N/A 2032-06-15 |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
32,000 | $0 | 32,000 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:00 pm |
N/A 2032-06-13 |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director |
20,250 | $0 | 20,250 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:10 pm |
N/A 2032-06-09 |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:42 pm |
N/A 2032-06-01 |
Adicet Bio Inc. | ACET | GORDON CARL L Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:25 pm |
N/A 2032-05-31 |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 5:45 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 7:06 pm |
N/A N/A |
Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner |
214,285 | $14 | 7,475,141 (Indirect) |
View |
| 2021-10-12 Conversion |
2021-10-14 5:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
31,990,686 | $0 | 499,150 (Indirect) |
View |
| 2021-10-06 Option Award |
2021-10-08 7:00 pm |
N/A 2031-10-05 |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
22,678 | $0 | 22,678 (Direct) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
0 | $0 | 16,213,668 (Indirect) |
View |
| 2021-10-04 Option Award |
2021-10-06 4:15 pm |
N/A 2031-10-03 |
Gemini Therapeutics Inc. | GMTX | GORDON CARL L Director 10% Owner |
17,245 | $0 | 17,245 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 7:44 pm |
N/A 2031-06-15 |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner |
16,625 | $0 | 16,625 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:27 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-04 7:23 pm |
N/A 2031-04-29 |
Adicet Bio Inc. | ACET | GORDON CARL L Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 5:03 pm |
N/A 2031-02-23 |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-18 9:41 pm |
N/A N/A |
Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner |
524,349 | $13 | 1,989,597 (Indirect) |
View |
Ownership |
2021-02-10 5:44 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | GORDON CARL L Director 10% Owner |
0 | $0 | 5,826,224 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:10 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
6,632,408 | $0 | 2,274,723 (Indirect) |
View |
Ownership |
2021-02-04 5:07 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
0 | $0 | 3,316,204 (Indirect) |
View |
| 2021-01-22 Equity Swap |
2021-01-26 5:06 pm |
N/A N/A |
Prevail Therapeutics Inc. | PRVL | GORDON CARL L Director 10% Owner |
13,822,463 | $0 | 0 (Indirect) |
View |
| 2020-12-07 Conversion |
2020-12-09 4:18 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
3,240,882 | $0 | 534,599 (Indirect) |
View |
| 2020-12-02 Option Award |
2020-12-04 06:03 am |
N/A 2030-12-02 |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
40,501 | $0 | 40,501 (Direct) |
View |
Ownership |
2020-12-02 9:07 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
0 | $0 | 3,097,929 (Indirect) |
View |
| 2020-09-17 Option Award |
2020-09-17 9:40 pm |
N/A 2030-09-17 |
Adicet Bio Inc. | ACET | GORDON CARL L Director |
6,048,452 | $0 | 1,012,662 (Direct) |
View |
Ownership |
2020-09-17 9:34 pm |
N/A N/A |
Adicet Bio Inc. | ACET | GORDON CARL L Director |
0 | $0 | 690,055 (Indirect) |
View |
Ownership |
2020-06-23 9:33 pm |
N/A N/A |
Compass Therapeutics Inc. | GORDON CARL L Director 10% Owner |
0 | $0 | 11,259,272 (Indirect) |
View | |
| 2020-06-17 Option Award |
2020-06-19 6:37 pm |
N/A 2030-06-17 |
Prevail Therapeutics Inc. | PRVL | GORDON CARL L Director 10% Owner |
17,000 | $0 | 17,000 (Direct) |
View |